Maria-Luisa Maccecchini
Amministratore Delegato presso ANNOVIS BIO, INC.
Patrimonio netto: 15 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Maria-Luisa Maccecchini
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Treventis Corp.
 Treventis Corp. BiotechnologyHealth Technology Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada.
7
| Holding Company | Biotechnology | 7 |
Translational Development Acquisition Corp.
 Translational Development Acquisition Corp. Financial ConglomeratesFinance Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.
6
| Private Company | Financial Conglomerates | 6 |
Annovis, Inc.
 Annovis, Inc. Chemicals: SpecialtyProcess Industries Annovis, Inc. develops, manufactures, and markets a wide variety of nucleic acid based for the life sciences sector. The company is headquartered in Aston, PA.
1
| Subsidiary | Chemicals: Specialty | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Maria-Luisa Maccecchini tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | General Counsel | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ASPEN TECHNOLOGY | Packaged Software | Chairman | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | General Counsel | |
| ORASURE TECHNOLOGIES, INC. | Medical Specialties | General Counsel | |
Riverstone Holdings LLC
 Riverstone Holdings LLC Investment ManagersFinance Riverstone Holdings LLC operates as an energy focused investment manager. It conducts buyout and growth capital investments in the exploration and production, midstream, oilfield services, power, and renewable sectors of the energy industry. The company was founded by David Matthew Leuschen and Pierre Fernard Lapeyre, Jr. in 2000 and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| TRAWS PHARMA, INC. | Biotechnology | Chairman Founder | |
Azevan Pharmaceuticals, Inc.
 Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Pharmaceuticals: Major | Chief Operating Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Drexel University | College/University | Graduate Degree Undergraduate Degree | |
| Birla Institute of Technology & Science | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree | |
Robin Hood Ventures
 Robin Hood Ventures Investment ManagersFinance Robin Hood Ventures (RHV) is a venture capital firm founded in 1999 by Rob weber. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor | |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor | |
| California University of Pennsylvania | College/University | Undergraduate Degree | |
| Dalhousie University | College/University | Corporate Officer/Principal | |
| Fairleigh Dickinson University | College/University | Masters Business Admin Undergraduate Degree | |
| Purdue University | College/University | Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal | |
Therakos, Inc.
 Therakos, Inc. Medical/Nursing ServicesHealth Services Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
| Osmania University | College/University | Doctorate Degree | |
Topaz Power Group LLC
 Topaz Power Group LLC Oilfield Services/EquipmentIndustrial Services Topaz Power Group LLC owns and operates natural gas and oil-fired plants. It operates a natural gas combined cycle plant and a natural gas steam power generating facility. The company was founded in 2004 and is headquartered in Austin, Texas. | Oilfield Services/Equipment | Director/Board Member | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Founder | |
| Association of Biotechnology Led Enterprises | President | ||
| Canada Research Chairs Program | General Government | Corporate Officer/Principal | |
| Whelan & Co. LLC | President | ||
DeNovaMed, Inc.
 DeNovaMed, Inc. Pharmaceuticals: MajorHealth Technology DeNovaMed, Inc. develops an antibiotic to treat infections caused by drug-resistant bacteria or superbugs. It focuses in the areas of Gram-positive infections, methicillin-resistant Staph and vancomycin-resistant Enterococcus pose a threat to patients in hospitals and community health facilities by producing skin, wound and systemic infections. The firm also has an ongoing discovery program for Gram-negative adjuvants, which can improve the efficacy of older antibacterial. The company was founded by Donald F. Weaver, Christopher R. McMaster and David Byers in 2006 and is headquartered in Halifax, Canada. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| Fels Institute of Government | College/University | Director/Board Member | |
| IANTHUS CAPITAL HOLDINGS, INC. | Agricultural Commodities/Milling | Director/Board Member | |
| Stone Capital Partners LLC | Founder Corporate Officer/Principal | ||
| The Tisch Cancer Institute at Mount Sinai | Corporate Officer/Principal | ||
| Opford Foundation | Founder | ||
| THE LION ELECTRIC COMPANY | Financial Conglomerates | Founder Corporate Officer/Principal | |
| NORTHERN GENESIS ACQUISITION CORP. III | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
| Vilua, Inc. | Director/Board Member | ||
| ASPEN TECHNOLOGY, INC. | Packaged Software | Chairman | |
CrisprBits Pvt Ltd.
 CrisprBits Pvt Ltd. BiotechnologyHealth Technology CrisprBits Pvt Ltd is an Indian company that specializes in using CRISPR, a gene-editing technology, to develop affordable solutions in the life sciences. Additionally, they are exploring the application of CRISPR in the food and fermentation industry to impact climate. The company is based in Vikas Marg, India and was founded by Vijay Chandru, Sunil Arora, Bharat Jobanputra, Aditya Sarda, and Rajeev Kohli. The company is currently developing pervasive diagnostics and surveillance tests for infectious and inherited diseases, cancer, and predicting genetic diseases. The company is also working on gene editing and splicing for therapeutics such as CAR-T cells and induced pluripotent stem cells (iPSCs). | Biotechnology | Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| India | 6 |
| Canada | 6 |
| Svizzera | 2 |
Settori
| Consumer Services | 17 |
| Health Technology | 12 |
| Finance | 10 |
| Technology Services | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 89 |
| Corporate Officer/Principal | 77 |
| Founder | 29 |
| Undergraduate Degree | 22 |
| Chairman | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Michael Hoffman | 39 |
| Paul Brooke | 32 |
| Robert Whelan | 16 |
| L. William McIntosh | 15 |
| Donald Keyser | 13 |
| Panna Sharma | 12 |
| Greg Harriman | 11 |
| Bruce C. Galton | 11 |
| Claudine Bruck | 11 |
| Vijay Chandru | 11 |
| Reid McCarthy | 10 |
| Jeffrey McGroarty | 9 |
| Desh S. K. Govender | 9 |
| Leslie W. Kreis | 8 |
| Eve M. Damiano | 8 |
- Borsa valori
- Insiders
- Maria-Luisa Maccecchini
- Connessioni Società
